News Controversial diabetes drug not associated with increased CV - TopicsExpress



          

News Controversial diabetes drug not associated with increased CV risk in patients with CAD Treatment with rosiglitazone was not associated with an increased risk of major ischemic cardiovascular events in a large, international study of patients with type 2 diabetes and coronary artery disease. "Our analyses did not detect any ... » clinicalendocrinologynews/specialty-focus/diabetes/single-article-page/controversial-diabetes-drug-not-associated-with-increased-cv-risk-in-patients-with-cad/
Posted on: Mon, 12 Aug 2013 02:48:12 +0000

Trending Topics



Recently Viewed Topics




© 2015